William Slayton, M.D.

William Slayton, M.D.

(352) 273-9120

Request an Appointment

Publications

A genomics-informed computational biology platform prospectively predicts treatment responses in AML and MDS patients
Blood Advances
2019

Dasatinib Plus Intensive Chemotherapy in Children, Adolescents, and Young Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of Children's Oncology Group Trial AALL0622.
Journal of Clinical Oncology
2018

Post-Transplant Lymphoproliferative Disorder (Ptld): Single Institutional Experience of 141 Patients
Experimental Hematology & Oncology
2017

Minimal Change Disease As Initial Presentation of Alk-Positive Anaplastic Large-Cell Lymphoma in a Pediatric Patient
Case Reports in Oncology
2017

Importance of baseline PET/CT imaging on radiation field design and relapse rates in patients with Hodgkin lymphoma
Advances in radiation oncology
2017

Proton Therapy for Pediatric Hodgkin Lymphoma
Pediatric Blood & Cancer
2016

Proton Therapy to the Subdiaphragmatic Region in the Management of Patients With Hodgkin Lymphoma
Leukemia & Lymphoma
2015

Near Fatal Presentation of Neuro-Degenerative Langerhans Cell Histiocytosis
Pediatric Blood & Cancer
2015

Generating Potent Chimeric Antigen Receptor T Cells Using Interleukin 15 Receptor Alpha Signal as a Co-Stimulatory Domain
Pediatric Blood & Cancer
2015

Philadelphia Chromosome-Negative Very High-Risk Acute Lymphoblastic Leukemia in Children and Adolescents: Results From Children's Oncology Group Study Aall0031

2014

Long-Term Follow-Up of Imatinib in Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Children's Oncology Group Study Aall0031

2014

Involved-node proton therapy in combined modality therapy for Hodgkin lymphoma: results of a phase 2 study
International Journal of Radiation Oncology Biology Physics
2014

Integrin VLA-5 and FAK are Good Targets to Improve Treatment Response in the Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Frontiers in Oncology
2014

Molecular Mechanisms of Platelet and Stem Cell Rebound After 5-Fluorouracil Treatment
Experimental Hematology
2013

Conditional Deletion of Jak2 Reveals An Essential Role in Hematopoiesis Throughout Mouse Ontogeny: Implications for Jak2 Inhibition in Humans
PLoS One
2013

Outstanding Early Responses With Dasatinib and Intensive Chemotherapy in Pediatric Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph Plus All): Children's Oncology Group (Cog) Trial Aall0622
Pediatric Blood & Cancer
2012

Juvenile Myelomonocytic Leukemia in a 16-Year-Old With Noonan Syndrome: Case Report
Journal of Pediatric Hematology/Oncology
2012

Improving the Therapeutic Ratio in Hodgkin Lymphoma Through the Use of Proton Therapy
Oncology
2012

Continuous Dose Dasatinib Is Safe and Feasible in Combination With Intensive Chemotherapy in Pediatric Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ All): Children's Oncology Group (Cog) Trial Aall0622
Blood
2012

Characteristics of Thawed Autologous Umbilical Cord Blood
Transfusion
2012

Screening Small Molecule Inhibitors of Vla-5 To Block the Interaction Between Acute Lymphoblastic Leukemia With Ph Plus and Their Microenvironment
Blood
2010

Post-Transplant Lymphoproliferative Disorders in Children: Recent Outcomes and Response To Dual Rituximab/Chemotherapy Combination
American Journal of Transplantation
2010

Post-Transplant Lymphoproliferative Disorder in Children: Recent Outcomes and Response To Dual Rituximab/Low-Dose Chemotherapy Combination
Pediatric Transplantation
2010

Neonatal Megakaryocytes Do Not Mature Normally in the Absence of Thrombopoietin in Vivo: Potential Role of Developmental Differences in Cxcr4 Expression
Blood
2010

Intrinsic and Extrinsic Effects of Mafg Deficiency On Hematopoietic Recovery Following Bone Marrow Transplant
Experimental Hematology
2010

Differences Between Newborn and Adult Mice in Their Response To Immune Thrombocytopenia
Neonatology
2010

Post-Transplant Lymphoproliferative Disorder in Children: Recent Clinical Characteristics, Outcomes and Response To Dual Rituximab/Chemotherapy Combination
American Journal of Transplantation
2009

Mll/Af-4 Leukemic Cells Recruit New Blood Vessels But Do Not Incorporate Into Capillaries in Culture Or in a Nod/Scid Xenograft Model

2009

High Levels of Acetylated Low-Density Lipoprotein Uptake and Low Tyrosine Kinase With Immunoglobulin and Epidermal Growth Factor Homology Domains-2 (Tie2) Promoter Activity Distinguish Sinusoids From Other Vessel Types in Murine Bone Marrow
Circulation
2009

Congenital Cytopenias and Bone Marrow Failure Syndromes
Seminars in Perinatology
2009

Type 2B Von Willebrand Disease Associated With the Release of Platelet Agglutinates From Megakaryocytes in the Bone Marrow
Journal of Pediatric Hematology/Oncology
2008

Stable Integration of Recombinant Adeno-Associated Virus Vector Genomes After Transduction of Murine Hematopoietic Stem Cells
Human Gene Therapy
2008

Recombinant Self-Complementary Adeno-Associated Virus Serotype Vector-Mediated Hematopoietic Stem Cell Transduction and Lineage-Restricted, Long-Term Transgene Expression in a Murine Serial Bone Marrow Transplantation Model
Human Gene Therapy
2008

Philadelphia Chromosome Negative (Ph-) Very High Risk (Vhr) Acute Lymphoblastic Leukemia (All) in Children and Adolescents: the Impact of Intensified Chemotherapy On Early Event Free Survival (Efs) in Children'S Oncology Group (Cog) Study Aall0031
Blood
2008

Optimization of Recombinant Adeno-Associated Viral Vectors for Human Beta-Globin Gene Transfer and Transgene Expression
Human Gene Therapy
2008

Bone Marrow Sinusoidal Endothelial Cells Undergo Nonapoptotic Cell Death and Are Replaced By Proliferating Sinusoidal Cells in Situ To Maintain the Vascular Niche Following Lethal Irradiation
Experimental Hematology
2008

The role of the donor in the repair of the marrow vascular niche following hematopoietic stem cell transplant.

2007

Stem cell research.
Paediatric respiratory reviews
2006

Differential effects of recombinant thrombopoietin and bone marrow stromal-conditioned media on neonatal versus adult megakaryocytes
Blood
2006

Developmental differences in megakaryocyte maturation are determined by the microenvironment.

2005

PU.1 supports proliferation of immature erythroid progenitors.
Leukemia Research
2004

The spleen is a major site of megakaryopoiesis following transplantation of murine hematopoietic stem cells.
Blood
2002